US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Diagnostic Markets for Women's Health (Pregnancy and Ovulation, Bone Density, Prenatal Screening, Ultrasound, Mammography, Pap Smear, Colposcopy, HPV, UTI, and Other Testing)
10/30/2014 | published by: Kalorama Information
... maternal-fetal medicine, as well as autoimmune disease and cystic fibrosis. At many clinics and practices focused on the health of women, a range of specialties are offered, which often results in a need for specific ...  |  read more...
USD 3,995
Ovarian Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of ovarian cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 248 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Breast Cancer Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... of breast cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors breast cancer technology. These deals tend to ...  |  read more...
USD 995
Ovarian Cancer Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... of ovarian cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors ovarian cancer technology. These deals tend to ...  |  read more...
USD 995
Human Papilloma Virus Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... in human papilloma virus partnering deals Top human papilloma virus deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Human Papilloma Virus Partnering 2009-2014 provides understanding and access ...  |  read more...
USD 995
Sexual Dysfunction Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering deals Top sexual dysfunction deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Sexual Dysfunction Partnering 2009-2014 provides understanding and access to the sexual dysfunction partnering deals ...  |  read more...
USD 695
Osteoarthritis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Uterine cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Uterine cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Cervical Dysplasia Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Cervical Dysplasia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Vasomotor Symptoms of Menopause - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Vasomotor Symptoms of Menopause, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Ovarian Cancer - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
... therapeutic development for Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,500
Breast Cancer Drug Pathway Analyzer 2014
11/4/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of breast cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 311 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Cervical Cancer Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... of cervical cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cervical cancer technology. These deals tend to ...  |  read more...
USD 695
Infertility Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Infertility Partnering 2009-2014 provides understanding and access to the infertility partnering deals and agreements entered into by the worlds ...  |  read more...
USD 695
Menopause Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Menopause Partnering 2009-2014 provides understanding and access to the menopause partnering deals and agreements entered into by the worlds ...  |  read more...
USD 695
Contraception Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Contraception Partnering 2009-2014 provides understanding and access to the contraception partnering deals and agreements entered into by the worlds ...  |  read more...
USD 995
Breast Cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Breast Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Ovarian Cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Ovarian Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Migraine Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Cervical Cancer Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Cervical Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Endometriosis Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Female Infertility Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Female Infertility in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
Menopause Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing ...  |  read more...
USD 670
Ovarian Cancer Drug Pipeline Update 2014
10/27/2014 | published by: BioSeeker Group AB
... an important secondary indication for existing and pipeline drugs. There are today 245 companies plus partners developing 347 drugs targeting ovarian cancer in development. In addition, there are 8 suspended drugs and the accumulated number ...  |  read more...
USD 6,746
Breast Cancer Drug Pipeline Update 2014
10/27/2014 | published by: BioSeeker Group AB
... and metastatic setting, the overall survival remains below five years. There are today 388 companies plus partners developing 549 drugs targeting breast cancer in development. In addition, there are 8 suspended drugs and the accumulated ...  |  read more...
USD 6,746
< prev 1    3  4  5  6  7  8  9  10